"Added description"

During the past decade, Michigan Institute of Urology-Town Center conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 28 clinical trials were completed, i.e. on average, 50.9% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 24 clinical trials were completed. i.e. 141.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Michigan Institute of Urology-Town Center" #1 sponsor was "National Cancer Institute (NCI)" with 17 trials, followed by "Alliance for Clinical Trials in Oncology" with 11 trials sponsored, "SWOG Cancer Research Network" with 10 trials sponsored, "Janssen Research & Development, LLC" with 6 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Michigan Institute of Urology-Town Center" #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Astellas Pharma Inc" with 2 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Michigan Institute of Urology-Town Center" are "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Prostate Cancer" (6 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "Stage IIIA Breast Cancer" (5 trials) and "Stage II Breast Cancer" (4 trials). Many other conditions were trialed in "Michigan Institute of Urology-Town Center" in a lesser frequency.

Most popular intervention types in "Michigan Institute of Urology-Town Center" are "Drug" (50 trials), "Other" (41 trials), "Biological" (18 trials), "Procedure" (13 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (20 trials), "Quality-of-Life Assessment" (16 trials), "Questionnaire Administration" (8 trials), "Computed Tomography" (7 trials) and "Biospecimen Collection" (6 trials). Other intervention names were less common.

The vast majority of trials in "Michigan Institute of Urology-Town Center" are 54 trials for "All" genders, 13 trials for "Male" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Michigan Institute of Urology-Town Center". undefined are not yet recruiting, 12 are recruiting, 35 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Michigan Institute of Urology-Town Center, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Michigan Institute of Urology-Town Center, 4 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".